首页> 外文期刊>British Journal of Cancer >A tumour-associated antigen from the pleural effusion of patients with squamous-cell carcinoma of lung
【24h】

A tumour-associated antigen from the pleural effusion of patients with squamous-cell carcinoma of lung

机译:肺鳞状细胞癌患者胸腔积液中的一种肿瘤相关抗原

获取原文
获取外文期刊封面目录资料

摘要

A fraction showing tumour-associated antigenic properties has been isolated from pleural effusions of patients with squamous-cell carcinoma of the lung. Purification of the material was accomplished by ion-exchange and affinity chromatography, and by immunoabsorbents. The antigenic activity was monitored by its inhibitory capacity in a specific complement-dependent cytotoxic system. The final fraction has a mol. wt. of approximately 1.7 X 10(5), as judged by gel filtration on Sephadex G200, and the main component appears to be a glycoprotein with N-acetyl-D-glucosamine groups. The most purified antigen preparation exhibited a highly selective capacity to inhibit in the cytotoxic assay and to bind, when labelled with 125I, to 2 specific antisera. The active fractions isolated from pleural effusions fully crossreacted with fractions prepared from squamous-cell carcinoma extracts. CEA and bacterial antigens were not detected in the material, and the presence of alpha-fetoprotein, HLA and blood-group antigens may be ruled out on account of their respective molecular weights.
机译:从肺鳞状细胞癌患者的胸腔积液中分离出具有肿瘤相关抗原特性的部分。通过离子交换和亲和色谱,以及通过免疫吸收剂来完成材料的纯化。通过在特定的补体依赖性细胞毒性系统中的抑制能力来监测抗原活性。最终级分具有摩尔。重量通过在Sephadex G200上进行凝胶过滤判断,其分子量约为1.7 X 10(5),主要成分似乎是具有N-乙酰基-D-葡萄糖胺基团的糖蛋白。最纯化的抗原制剂在细胞毒性测定中表现出高度选择性的抑制能力,并在用125 I标记时能结合2种特异性抗血清。从胸腔积液中分离出的活性成分与从鳞状细胞癌提取物中制备的成分完全交叉反应。在该材料中未检测到CEA和细菌抗原,并且由于其各自的分子量,可以排除甲胎蛋白,HLA和血型抗原的存在。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号